TELA Bio

TELA Bio

Health Care Equipment & Supplies
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy. Its growing product portfolio is purposefully designed to leverage the patient’s natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

$36M

Market Cap • 11/3/2026

2012

(14 years)

Founded

2019

(7 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

—

P/S

0,5

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

—

EPS

—

Market Cap

Market Cap

36M

EV

61,7M

EV/Revenue

0,8

EV/EBITDA

-1,9

EV/EBIT

-1,8

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-32,7%

Total Yield

-32,7%

Payout

0%

Retained Earnings

-421,1M

Profitability

Gross Margin

67,8%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

11,9%

Capex/Revenue

0,6%

Capex/D&A

47,9%

Capex/OCF

-1,5%

SBC/OCF

—

% PPE

5,7%

% Goodwill

0%

ROE

1232,5%

ROIC

—

Growth

CAGR Revenue 5Y

26,8%

CAGR Op. Income 5Y

3,8%

CAGR Net Income 5Y

5,2%

CAGR EPS 5Y

-18,9%

CAGR OCF 5Y

4,5%

Leverage

N.D./EBITDA

—

Debt/Equity

0%

Current Ratio

3

Quick Ratio

2,2

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium